PURE

What one share of PURE Bioscience holds

Miscellaneous Chemical Products

PURE Bioscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-04-30; the balance sheet is as of 2026-04-30.

Per-share figures
Sales$0.02
Profit−$0.02
Cash and investments$0.01
Debt$0.05
Book value−$0.04

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2011$0.10−$1.79$0.00−$1.32—$0.84
2012$0.14−$1.58$0.00−$1.00—$0.12
2013$0.08−$0.71$0.00−$0.36—−$0.08
2014$0.02−$0.43$0.00−$0.25—$0.00
2015$0.02−$0.19$0.00−$0.15—$0.06
2016$0.02−$0.25$0.01−$0.09—$0.08
2017$0.03−$0.10$0.00−$0.08—$0.02
2018$0.03−$0.11$0.00−$0.06—$0.02
2019$0.03−$0.09$0.00−$0.04—$0.02
2020$0.08$0.00$0.00$0.01—$0.06
2021$0.04−$0.03$0.01−$0.02—$0.04
2022$0.02−$0.04$0.00−$0.03—$0.04
2023$0.02−$0.04$0.00−$0.03—$0.00
2024$0.02−$0.03———−$0.03
2025$0.02−$0.02———−$0.05

Common questions about PURE Bioscience

How much does one share of PURE Bioscience earn?

Over the last 12 months, PURE Bioscience lost $0.02 for each share on $0.02 of sales.

Does PURE Bioscience pay a dividend?

PURE Bioscience didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is PURE Bioscience’s book value per share?

PURE Bioscience’s book value is negative (−$0.04 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of April 30, 2026.

How much cash and debt does each share of PURE Bioscience have?

Each share of PURE Bioscience has $0.01 of cash and investments and $0.05 of debt, as of April 30, 2026.

Has PURE Bioscience bought back shares?

PURE Bioscience’s share count rose about 2298% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.